Immunotherapy Clinical Trials in Xiamen, Fujian
4 recruitingXiamen, Fujian, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma
ChemotherapyGastroesophageal Junction AdenocarcinomaImmunotherapy+1 more
West China Hospital88 enrolled4 locationsNCT07072351
Recruiting
Phase 2
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC
ImmunotherapyInduction TherapyLocally Advanced Nasopharyngeal Carcinoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT07085234
Recruiting
Phase 2
SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy
ImmunotherapySBRTNasopharyngeal Cancinoma (NPC)
The First Affiliated Hospital of Xiamen University20 enrolled2 locationsNCT06676722
Recruiting
Phase 2
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Advanced Colorectal CarcinomaImmunotherapy
Fudan University208 enrolled10 locationsNCT06521866